Differences between urologists in the United States and Canada in the approach to prostate cancer

Journal of Urology

Volumn 163, Issue 5, 2000, Pages 1461-1466

  Fleshner, Neil ^a   Rakovitch, Eileen ^a   Klotz, Laurence ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Physician's practice patterns; Prostate; Prostatic neoplasms; Questionnaires; Surgery

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANADA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER SCREENING; CANCER STAGING; CASE FINDING; CLINICAL PRACTICE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; QUESTIONNAIRE; UNITED STATES; UROLOGY;

EID: 0034101742     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67643-4     Document Type: Article

References (25)

1. Etzioni, R., Legler, J. M., Feuer, E. J. et al: Cancer surveillance series: interpreting trends in prostate cancer - part III: quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst, 91: 1033, 1999
2. Hugosson, J. and Aus, G.: Natural course of localized prostate cancer: a personal view with a review of published papers. Anticancer Res, 17: 1441, 1997
3. Litwin, M. S., McGuigan, K. A., Shpall, A. I. et al: Recovery of health related quality of life in the year after radical prostatectomy: early experience. J Urol, 161: 515, 1999
4. Erbersdobler, A., Bardenhagen, P. and Henke, R. P.: Numerical chromosomal anomalies in latent adenocarcinomas of the prostate. Prostate, 38: 92, 1999
5. Birkmeyer, J. D., Sharp, S. M., Finlayson, S. R. et al: Variation profiles of common surgical procedures. Surgery, 124: 917, 1998
6. Redelmeier, D. A. and Fuchs, V. R.: Hospital expenditures in the United States and Canada. N Engl J Med, 328: 772, 1993
7. Iscoe, N. A., Naylor, C. D., Williams, J. I. et al: Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference? CMAJ, 150:1109, 1994
8. Crosby, F. E., Ventura, M. R. and Feldman, M. J.: Examination of a survey methodology: Dillman's Total Design Method. Nurs Res, 38:56, 1989
9. Fleiss, J.: The comparison of proportions from several independent samples. In: Statistical Methods for Rates and Proportions, 2nd ed. NewYork: Wiley, pp. 138-159, 1981
10. Fleshner, N. E. and Fair, W. R.: Indications for transition zone biopsy in the detection of prostatic carcinoma. J Urol, 157: 556, 1997
11. Stamey, T. A., Dietrick, D. D. and Issa, M. M.: Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen J Urol, 149: 510, 1993
12. Haukaas, S., Roervik, J., Halvorsen, O. J. et al: When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer? Br J Urol, 79: 770, 1997
13. Kindrick, A. V., Grossfeld, G. D., Stier, D. M. et al: Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database. J Urol, 160: 2102, 1998
14. Partin, A. W., Kattan, M. W., Subong, E. N. et al: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA, 277: 1445, 1997
15. Arai, Y., Kanamaru, H., Yoshimura, K. et al: Incidence of lymph node metastasis and its impact on long-term prognosis in clinically localized prostate cancer. Int J Urol, 5: 459, 1998
16. Zincke, H., Bergstralh, E. J., Larson-Keller, J. J. et al: Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment.: Evidence for favorable survival in patients with DNA diploid tumors. Cancer, suppl., 70: 311, 1992
17. Fair, W. R. and Scher, H. I.: Neoadjuvant hormonal therapy plus surgery for prostate cancer. The MSKCC experience.: Surg Oncol Clin N Am, 6: 831, 1997
18. Walsh, P. C. and Lepor, H.: The role of radical prostatectomy in the management of prostatic cancer. Cancer, suppl., 60: 526, 1987
19. Walsh, P. C.: Anatomic radical prostatectomy: evolution of the surgical technique. J Urol, part 2, 160: 2418, 1998
20. Litwin, M. S., Hays, R. D., Fink, A. et al: Quality-of-life outcomes in men treated for localized prostate cancer. JAMA, 273: 129, 1995
21. Kelly, W. K.: Endocrine withdrawal syndrome and its relevance to the management of hormone refractory prostate cancer. Eur Urol, suppl., 34: 18, 1998
22. National Cancer Institute of Canada: Canadian cancer statistics, 1998. Toronto: The Institute, p. 28, 1998
23. Gallagher, R. P. and Fleshner, N.: Prostate cancer: 3. Individual risk factors. CMAJ, 159: 807, 1998
24. Plawker, M. W., Fleisher, J. M., Vapnek, E. M. et al: Current trends in prostate cancer diagnosis and staging among United States urologists. J Urol, 158: 1853, 1997
25. Naylor, C. D. and Guyatt, G. H.: Users' guide to the medical literature. XI. How to use an article about a clinical utilization review. Evidence-Based Medicine Working Group. JAMA, 275: 1435, 1996